On Friday, Warner Chilcott, which is based in the Bermudas, filed an IPO designed to raise up to a billion dollars. The company develops drugs for women's health and dermatological conditions. It has gained six FDA approvals. Warner Chilcott had been a subsidiary of Warner-Lambert and was acquired in early 2005 for $3.1 billion. This was one of the most ambitious IPOs filed this year.

- here's the AP report on the IPO

PLUS: CoGenesys, a biotech company formed by senior executives from HGS, has raised $55 million in its first round. Company executives say they intend to advance new products to Phase I and Phase II stages and then look for a licensing partner. Release

ALSO: TetraLogic Pharmaceuticals has raised $36 million in its second round of funding. Release

AND: Panacea Pharmaceuticals has raised $8.9 million in its fourth round. Release